Intravenous thrombolysis after reversal of dabigatran by idarucizumab: a moment to be a pioneer

被引：13
|
作者：
Turine, G. [1 ]
Peeters, A. [1 ]
Hermans, C. [2 ]
Eeckhoudt, S. [3 ]
Duprez, T. [4 ]
机构：
[1] Clin Univ St Luc, Dept Neurol, 10 Ave Hippocrate 10, B-1200 Brussels, Belgium
[2] Clin Univ St Luc, Div Haematol, Haemostasis & Thrombosis Unit, 10 Ave Hippocrate 10, B-1200 Brussels, Belgium
[3] Clin Univ St Luc, Haemostasis & Thrombosis Lab, Dept Biol Clin, B-1200 Brussels, Belgium
[4] Clin Univ UCL St Luc, Dept Radiol, Neuroradiol Sect, 10 Ave Hippocrate 10, B-1200 Brussels, Belgium
来源：
ACTA NEUROLOGICA BELGICA | 2017年 / 117卷 / 03期
关键词：
Ischemic stroke; Intravenous thrombolysis; Dabigatran; Idarucizumab;
D O I：
10.1007/s13760-017-0751-5
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：753 / 755
页数：3
相关论文
共 50 条
  • [31] Systemic thrombolysis and endovascular thrombectomy in severe acute ischemic stroke after dabigatran reversal with idarucizumab
    Binet, Quentin
    Hammer, Frank D.
    Rocrelle, Olivia
    Peeters, Andre
    Scavee, Christophe
    Hermans, Cedric
    CLINICAL CASE REPORTS, 2018, 6 (04): : 698 - 701
  • [32] Reversal of dabigatran by intraosseous or intravenous idarucizumab in a porcine polytrauma model
    Akman, N.
    Braunschweig, T.
    Honickel, M.
    Schuett, K.
    Schoechl, H.
    Stoppe, C.
    Rossaint, R.
    Grottke, O.
    BRITISH JOURNAL OF ANAESTHESIA, 2018, 120 (05) : 978 - 987
  • [33] Idarucizumab The Antidote for Reversal of Dabigatran
    Eikelboom, John W.
    Quinlan, Daniel J.
    van Ryn, Joanne
    Weitz, Jeffrey I.
    CIRCULATION, 2015, 132 (25) : 2412 - 2422
  • [34] Systemic Thrombolysis in Acute Ischemic Stroke after Dabigatran Etexilate Reversal with Idarucizumab-A Case Report
    Tireli, Derya
    He, Jun
    Nordling, Mette Maria
    Wienecke, Troels
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2017, 26 (07): : E123 - E125
  • [35] Incomplete dabigatran reversal with idarucizumab
    Steele, Aaron P.
    Lee, Jin A.
    Dager, William E.
    CLINICAL TOXICOLOGY, 2018, 56 (03) : 216 - 218
  • [36] Dabigatran Reversal with Idarucizumab Reply
    Pollack, Charles V., Jr.
    Reilly, Paul A.
    Weitz, Jeffrey I.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (17): : 1691 - 1692
  • [37] Intravenous alteplase and endovascular clot retrieval following reversal of dabigatran with idarucizumab
    Tse, Dominic M.
    Young, Laura
    Ranta, Annemarei
    Barber, P. A.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 (05): : 549 - +
  • [38] Treatment With Intravenous Alteplase for Acute Ischemic Stroke After Reversal of Dabigatran With Idarucizumab: A Case Study
    Jala, Sheila
    O'Brien, Elizabeth
    JOURNAL OF NEUROSCIENCE NURSING, 2019, 51 (01) : 21 - 25
  • [39] Intravenous alteplase and endovascular clot retrieval following reversal of dabigatran with idarucizumab
    Tse, D. M.
    Young, L.
    Ranta, A.
    Barber, P. A.
    INTERNATIONAL JOURNAL OF STROKE, 2017, 12 : 36 - 37
  • [40] INTRAVENOUS THROMBOLYSIS AFTER IDARUCIZUMAB APPLICATION IN STROKE PATIENTS RECEIVING DABIGATRAN THERAPY: SLOVENIAN CASE SERIES
    Oblak, J. Pretnar
    Frol, S.
    Sabovic, M.
    INTERNATIONAL JOURNAL OF STROKE, 2020, 15 (1_SUPPL) : 118 - 118
12345